BCSC1 Polyclonal Antibody
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-5994R |
| Product Name | BCSC1 Polyclonal Antibody |
| Applications |
ELISA
IHC-P
IHC-F
IF(IHC-P)
IF(IHC-F)
IF(ICC)
|
| Reactivity | Mouse, Rat |
| Predicted Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human BCSC1 |
| Immunogen Range | 51-150/786 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 4013 |
| Subcellular location | Nucleus |
| Synonyms | Breast cancer suppressor candidate 1; LOH11CR2A; LHR2A; LOH11CR2A; BCSC 1; BCSC-1; BCSC1; Breast cancer suppressor candidate-1; Loss of heterozygosity 11 chromosomal region 2 gene A; Loss of heterozygosity 11 chromosomal region 2 gene A protein; Ortholog of mouse AW551984; VMA5A_HUMAN; von Willebrand factor A domain containing 5A; von Willebrand factor A domain-containing protein 5A; Vwa5a. |
| Background | May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis. |
| Application Dilution | |
| ELISA | 1:500-1000 |
| IHC-P | 1:200-400 |
| IHC-F | 1:100-500 |
| IF(IHC-P) | 1:50-200 |
| IF(IHC-F) | 1:50-200 |
| IF(ICC) | 1:50-200 |